Skip to content

Cullinan Therapeutics, Inc. CGEM Distributions to noncontrolling interests

Distributions to noncontrolling interests at other companies

HES
Hess MidstreamHESM
$59.8M-23.4%
Cabot Corporation logo
Cabot CorporationCBT
$34M
RadNet logo
RadNetRDNT
$2.4M+163%
Piper Sandler logo
Piper SandlerPIPR
$1.17M-75.9%
Sonoco Products logo
Sonoco ProductsSON
$0-100%
Belden logo
BeldenBDC
$0-100%

Other financials

Income statement

See full
Revenue-
Operating income-$53.7M+2.4%
Net income-$49.7M-2.4%
EPS (diluted)-$0.69+24.2%

Balance sheet

See full
Cash & equivalents$75.1M-2.1%
Total debt$2.4M+29.5%
Total equity$408.7M-30.8%
Total assets$403.0M-30.5%

Cash flow

See full
Operating cash flow-$46.0M-6.7%
CapEx$11.0K
Free cash flow-$38.1M-4.1%

Valuation

See full
Market cap$1.08B+151%
Enterprise value$1.01B+181%

Profitability

See full
Operating margin-358.7%
Net margin-346.1%

Returns & leverage

See full
Return on equity-44%+26.2pp
Debt / equity0.0×
Current ratio10.3×-1.3×

Where this comes from

Reported directly by Cullinan Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToMinorityShareholders.

The official record: Cullinan Therapeutics, Inc.’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s distributions to noncontrolling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s distributions to noncontrolling interests?
Cullinan Therapeutics, Inc. (CGEM) reported distributions to noncontrolling interests of $0 in Q4 2025.
What does distributions to noncontrolling interests mean?
Cash distributions paid to minority interest holders from subsidiaries not fully owned by the parent.